Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer halts distribution of anti-smoking drug after finding carcinogen

06/24/2021 | 04:47pm EDT

June 24 (Reuters) - Pfizer Inc said on Thursday it is pausing distribution of its anti-smoking treatment, Chantix, after it found elevated levels of cancer-causing agents called nitrosamines in the pills.

The drugmaker is also recalling a number of lots of the anti-smoking drug.

(Reporting by Dania Nadeem in Bengaluru;Editing by Arun Koyyur)


ę Reuters 2021
All news about PFIZER, INC.
03:10aThai hospital tycoon who promised Pfizer vaccine says deal now unlikely
RE
02:46aPFIZER : South Africa quickens vaccine drive, gets more doses from US
AQ
08/03ASTRAZENECA : Chilean study shows variations in success of COVID-19 vaccines
RE
08/03SECTOR UPDATE : Health Care Stocks Extending Gains Ahead of Tuesday Close
MT
08/03SECTOR UPDATE : Health Care Stocks Advancing Tuesday
MT
08/03THE LATEST : NYC: Vaccination proof for indoor dining, gyms
AQ
08/03PFIZER : Thinking about trading options or stock in Solaredge Technologies, Zoom..
PR
08/02INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Pfizer
MT
08/02Global markets live: Square, Pfizer, Zoom, HSBC, Ferrari
08/02Fancy a Covid jab? Here are all the free walk-in sites open in London
AQ
More news
Financials (USD)
Sales 2021 79 586 M - -
Net income 2021 18 722 M - -
Net Debt 2021 26 885 M - -
P/E ratio 2021 13,3x
Yield 2021 3,45%
Capitalization 256 B 256 B -
EV / Sales 2021 3,55x
EV / Sales 2022 4,29x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 45,68 $
Average target price 43,82 $
Spread / Average Target -4,07%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.24.10%255 703
JOHNSON & JOHNSON10.81%453 498
ROCHE HOLDING AG13.88%339 298
NOVARTIS AG0.14%225 528
ELI LILLY AND COMPANY51.62%224 166
NOVO NORDISK A/S36.15%212 792